Ellevest Inc’s Aura Biosciences AURA Stock Holding History

Ellevest Inc’s Portfolio AURA Stock Details AURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-13	Closed	-$121	–	469
2023 Q1	$121	Buy	+13	New	+$135	﹤0.01%	1802

Other funds holding AURA

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Ellevest Inc's AURA Position: Q2 2023 in Review

Ellevest Inc sold out of Aura Biosciences (AURA) in Q2 2023, closing a stake of 13 shares — an estimated $121 sold.

Ellevest Inc first reported a position in AURA in Q1 2023 and held it in 1 quarter. The position peaked at $121 in Q1 2023. 59 funds tracked by Wall St. Rank hold AURA as of Q2 2023.

Ellevest Inc reported no remaining Aura Biosciences position as of Q2 2023 after selling out during the quarter.
Ellevest Inc sold 13 Aura Biosciences shares in Q2 2023, an estimated $121.
Ellevest Inc first reported a position in Aura Biosciences in Q1 2023 and held it in 1 quarter.
Ellevest Inc's Aura Biosciences position peaked at $121 in Q1 2023.
59 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.